Episode
Gavi Phasing Out Thimerosal Vaccines, U.S. Funding at Risk
- Published
- May 23, 2026
- Duration seconds
- 119
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/us-news-today-2-min-news-the-daily-news-now-7023297/episodes/gavi-phasing-out-thimerosal-vaccines-u-s-funding-at-risk/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/us-news-today-2-min-news-the-daily-news-now-7023297/gavi-phasing-out-thimerosal-vaccines-u-s-funding-at-risk.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Gavi, the global vaccine alliance, is phasing out thimerosal-based vaccines, potentially unlocking $600 million in U.S. funding. This move addresses Health and Human Services Secretary Robert F. Kennedy Jr.s safety concerns and could prevent a resurgence of deadly diseases in developing countries. Support the show: Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN: [email protected] This is an automated, high-level news summary based on public reporting. Report issues to [email protected]. View sources & latest updates: https://sources.thednn.ai/563b407c045a1e2d